• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cosmos Health Inc. - Common Stock (NQ:COSM)

    0.2045 -0.0021 (-1.02%)
    Streaming Delayed Price Updated: 10:52 AM EDT, Aug 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Cosmos Health Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term
    Innova is backed by leading investors and healthcare groups: Alkhabeer Capital, with more than $2.5 billion AUM; Tamer Group, a pharma manufacturing partner to Astellas and Daiichi Sankyo; and Cigalah... 
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Launches Subscription Model
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Authorizes Up to $5 Million Share Repurchase Program
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit
    Company at a Turning Point — Moving the Business to a Different Level, With Growing Revenue and a Roadmap Toward Improved Profitability 
    From Cosmos Health Inc.
    Via GlobeNewswire
    News headline image
    Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines
    From Cosmos Health Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.